TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25330169

Group type: EXPERIMENTAL
Intervention: Information and telephone-guided access to community support
Number of subjects: 436

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 436
Study: 22331759

Group type: EXPERIMENTAL
Intervention: Test A (Glycomet SR)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Test B (Bigomet SR)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Reference product
Number of subjects: 18
Study: 20219962

Group type: EXPERIMENTAL
Intervention: Vitamin D(3) supplements (1200 IU/d)
Number of subjects: 334

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 334
Study: 17617938

Group type: EXPERIMENTAL
Intervention: Virgin olive oil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Common olive oil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Refined olive oil
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Olive oils rich in phenolic compounds
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15613438

Group type: EXPERIMENTAL
Intervention: Oral calcium administration (1 g calcium gluconate)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Peptone loading test (10 g protein hydrolyzed)
Number of subjects: 30
Study: 11849571

Group type: EXPERIMENTAL
Intervention: midazolam 0.5 mg x kg(‐1) mixed with sodium citrate
Number of subjects: 40

Group type: COMPARATOR
Intervention: midazolam 0.5 mg x kg(‐1) mixed with Hawaiian fruit punch
Number of subjects: 40
Study: 10756609

Group type: EXPERIMENTAL
Intervention: Telemarketing
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Personal marketing
Number of subjects: 614

Group type: EXPERIMENTAL
Intervention: Postal marketing
Number of subjects: 614
Study: 8873835

Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanic acid (1.2 g i.v. every 8 hours for 3-4 days, followed by 625 mg orally every 8 hours until labor)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Amoxicillin and clavulanic acid
Number of subjects: 75
Study: 1824374

Group type: EXPERIMENTAL
Intervention: Injection pen system (Nordiject) for administration of B-hGH (Norditropin)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Syringe (4 IU/ml)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Injection pen (Nordiject) (12 IU/ml)
Number of subjects: 27
Study: 6188895

Group type: EXPERIMENTAL
Intervention: Digoxin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 30629717

Group type: EXPERIMENTAL
Intervention: Fortified rice (FFR)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Non-fortified rice (non‐FFR)
Number of subjects: 800
Study: 30567952

Group type: EXPERIMENTAL
Intervention: 9-item Morisky Medication Adherence Scale (MMAS-9)
Number of subjects: 0
Study: 27909034

Group type: EXPERIMENTAL
Intervention: Standard care plus formal Advance Care Planning (ACP) intervention
Number of subjects: 210

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Standard care plus formal ACP intervention
Number of subjects: 210
Study: 25166719

Group type: EXPERIMENTAL
Intervention: MK-5442 (2.5, 5, 7.5, 10, or 15 mg)
Number of subjects: 383

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: MK-5442 (higher doses)
Number of subjects: 383
Study: 23020659

Group type: EXPERIMENTAL
Intervention: Chlorhexidine Chips (PerioC)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Matrix Chips (MatrixC)
Number of subjects: 60
Study: 18773914

Group type: EXPERIMENTAL
Intervention: Artificially sweetened solutions (aspartame concentrations of 0, 0.01, 0.03, 0.08, and 0.28%)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy women)
Number of subjects: 21
Study: 17635944

Group type: EXPERIMENTAL
Intervention: Water deprivation for 28 hours
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hypertonic saline infusion combined with thirsting for 17 hours
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hypotonic saline infusion with iv desmopressin during free water intake
Number of subjects: 24
Study: 15832114

Group type: EXPERIMENTAL
Intervention: Low-residue diet (normal breakfast followed by low-residue lunch)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard diet (light breakfast followed by clear liquids)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Low-residue diet
Number of subjects: 200
Study: 11079257

Group type: EXPERIMENTAL
Intervention: 80 mg/day simvastatin and 2 mg folic acid/0.8 mg vitamin B12 daily (combination group)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: 80 mg/day simvastatin and placebo vitamins (simvastatin alone group)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: 2 mg folic acid/0.8 mg vitamin B12 daily and placebo simvastatin (vitamins alone group)
Number of subjects: 141
Study: 9145970

Group type: EXPERIMENTAL
Intervention: Antimicrobial prophylaxis prior to SWL
Number of subjects: 1482

Group type: COMPARATOR
Intervention: Placebo/no treatment
Number of subjects: 1482

Group type: COMPARATOR
Intervention: Antimicrobial prophylaxis versus no prophylaxis
Number of subjects: 1482
Study: 8159920

Group type: EXPERIMENTAL
Intervention: Castration (orchidectomy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pamidronate (bisphosphonate)
Number of subjects: 0
Study: 3096460

Group type: EXPERIMENTAL
Intervention: Night and day nursery (light and noise reduced between 7 pm and 7 am)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control nursery (light and noise not reduced)
Number of subjects: 41
Study: 3164333

Group type: EXPERIMENTAL
Intervention: Guided tissue regeneration surgical treatment with teflon membrane and chlorhexidine gluconate rinses
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control treatment procedure (not specified in detail)
Number of subjects: 21
Study: 31587431

Group type: EXPERIMENTAL
Intervention: Er:YAG laser debridement
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sharp debridement
Number of subjects: 22
Study: 30402951

Group type: EXPERIMENTAL
Intervention: Berberine (BBR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of BBR and rosuvastatin
Number of subjects: 0
Study: 28447186

Group type: EXPERIMENTAL
Intervention: High-Volume (HV; 8 sets of 10 repetitions)
Number of subjects: 12

Group type: COMPARATOR
Intervention: High-Intensity (HI; 8 sets of 3 repetitions)
Number of subjects: 12
Study: 25847579

Group type: COMPARATOR
Intervention: Streamlined trial using mobile devices and internet for consent and data entry; participants receive an iPad and EasyOne spirometer for online visits and symptom reporting during an 8-week run-in and a 12-week study period.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Open-label Advair 250/50 twice daily for 8 weeks followed by randomization to Advair 250/50, Flovent 250, or Advair 100/50, given 1 inhalation twice daily.
Number of subjects: 0
Study: 23245760

Group type: EXPERIMENTAL
Intervention: GSK1521498 (mu-opioid receptor antagonist)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 21194823

Group type: EXPERIMENTAL
Intervention: Comprehensive program of secondary prevention of cardiovascular disease
Number of subjects: 1224

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1224
Study: 18388845

Group type: EXPERIMENTAL
Intervention: Medicare-based algorithm for measuring chemotherapy-related toxicities
Number of subjects: 175

Group type: COMPARATOR
Intervention: CALGB data
Number of subjects: 175
Study: 15994064

Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg MPH
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1.0 mg/kg MPH
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 14578916

Group type: EXPERIMENTAL
Intervention: Individualized treatment strategy (IND)
Number of subjects: 443

Group type: EXPERIMENTAL
Intervention: Stepwise treatment strategy (STEP)
Number of subjects: 443
Study: 10953061

Group type: EXPERIMENTAL
Intervention: Nonlinear critical velocity model
Number of subjects: 16

Group type: COMPARATOR
Intervention: Linear critical velocity models
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Critical velocity (CV)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Maximal oxygen consumption (VO(2)max)
Number of subjects: 16
Study: 9579942

Group type: EXPERIMENTAL
Intervention: Ganaxolone (doses ranging from 50 to 1,500 mg)
Number of subjects: 96
Study: 8265871

Group type: EXPERIMENTAL
Intervention: Broad-spectrum antimicrobial agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cytokines and other biological agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Peripheral stem cell reconstitution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gene insertion into hematopoietic stem cells
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rational use of antibiotics
Number of subjects: 0
Study: 3533124

Group type: EXPERIMENTAL
Intervention: Captopril (50 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31597554

Group type: EXPERIMENTAL
Intervention: Simple knee sleeve
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Simple sleeve with patella cutout
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 17
Study: 28102582

Group type: EXPERIMENTAL
Intervention: Preventive Cognitive Therapy (PCT) with ADM tapering
Number of subjects: 289

Group type: EXPERIMENTAL
Intervention: Preventive Cognitive Therapy (PCT) with maintenance ADM
Number of subjects: 289

Group type: COMPARATOR
Intervention: Maintenance ADM alone
Number of subjects: 289
Study: 26298304

Group type: EXPERIMENTAL
Intervention: Rescue PCI with manual thrombus aspiration (TA)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Rescue PCI without manual thrombus aspiration (NTA)
Number of subjects: 70
Study: 23255379

Group type: EXPERIMENTAL
Intervention: Group-based cognitive behaviour therapy (CBT) anger management intervention facilitated by lay therapists.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lay therapist role in facilitating CBT groups.
Number of subjects: 0
Study: 22024003

Group type: EXPERIMENTAL
Intervention: Family cognitive behavioral therapy (FCBT)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Psychoeducation plus relaxation training (PRT)
Number of subjects: 71
Study: 19478423

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 0
Study: 16792052

Group type: EXPERIMENTAL
Intervention: Chlorhexidine-containing chewing gum (5 mg of chlorhexidine diacetate)
Number of subjects: 0
Study: 14660273

Group type: EXPERIMENTAL
Intervention: Long pulse Nd:YAG laser (1064nm)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intense pulse light (IPL) system
Number of subjects: 11
Study: 10886466

Group type: EXPERIMENTAL
Intervention: Valette
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Neorlest
Number of subjects: 63
Study: 9310931

Group type: EXPERIMENTAL
Intervention: 3 million units (MU) of human lymphoblastoid interferon‐alpha‐n1 (Wellferon) three times per week for either 6 or 12 months
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 5 million units (MU) of human lymphoblastoid interferon‐alpha‐n1 (Wellferon) three times per week for either 6 or 12 months
Number of subjects: 38
Study: 8152983

Group type: EXPERIMENTAL
Intervention: Ketac Silver (silver cermet-ionomer cement)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Delton (conventional, autopolymerizing BIS-GMA resin sealant)
Number of subjects: 53
Study: 2423783

Group type: EXPERIMENTAL
Intervention: Indoramin (average dose of 50 mg every 12 h in 11 patients)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (n = 10)
Number of subjects: 21
Study: 30989176

Group type: EXPERIMENTAL
Intervention: Blood DNA methylation profile
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Methylation analysis
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Genetic association analysis
Number of subjects: 1552

Group type: EXPERIMENTAL
Intervention: Pathway analysis
Number of subjects: 1552
Study: 29510953

Group type: EXPERIMENTAL
Intervention: Use of tourniquet during the entire procedure (Group A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Use of tourniquet only during cementation (Group B)
Number of subjects: 54
Study: 28811120

Group type: EXPERIMENTAL
Intervention: Performance pay based on nutritional status of children
Number of subjects: 4000

Group type: EXPERIMENTAL
Intervention: Fixed bonuses
Number of subjects: 4000

Group type: COMPARATOR
Intervention: Control group receiving standard salaries
Number of subjects: 4000
Study: 25681488

Group type: EXPERIMENTAL
Intervention: Automated feedback system
Number of subjects: 24

Group type: COMPARATOR
Intervention: Nonfeedback group
Number of subjects: 24
Study: 24083021

Group type: EXPERIMENTAL
Intervention: TOGETHER group (active weight loss program)
Number of subjects: 132

Group type: COMPARATOR
Intervention: ALONE group (only primary participant attended treatment)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Dietary changes (calorie and fat intake)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Physical activity changes
Number of subjects: 132
Study: 21931073

Group type: EXPERIMENTAL
Intervention: manidipine/delapril combination (10/30 mg/d)
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: delapril (30 mg/d)
Number of subjects: 380

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 380

Group type: EXPERIMENTAL
Intervention: manidipine/delapril combination
Number of subjects: 380
Study: 18245680

Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 507

Group type: COMPARATOR
Intervention: Resin-based composite
Number of subjects: 507
Study: 16339055

Group type: EXPERIMENTAL
Intervention: Dietary folate intake
Number of subjects: 37916

Group type: EXPERIMENTAL
Intervention: Dietary vitamin B(6) intake
Number of subjects: 37916

Group type: COMPARATOR
Intervention: Total folate intake
Number of subjects: 37916

Group type: COMPARATOR
Intervention: Total vitamin B(6) intake
Number of subjects: 37916

Group type: COMPARATOR
Intervention: Multivitamin supplements
Number of subjects: 37916
Study: 12588384

Group type: EXPERIMENTAL
Intervention: Autologous blood therapy (ABT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 10917114

Group type: EXPERIMENTAL
Intervention: Oral estradiol 1 mg daily
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8768844

Group type: EXPERIMENTAL
Intervention: L-692,429 (0.05 mg/kg · h) for 24 h (low dose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: L-692,429 (0.1 mg/kg · h) for 12 h, then saline for 12 h (high dose)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: GHRH (1 μg/kg, iv) given 30 min before the end of each 24-h treatment
Number of subjects: 6

Group type: COMPARATOR
Intervention: Saline for 24 h (control)
Number of subjects: 6
Study: 2070134

Group type: EXPERIMENTAL
Intervention: Candida protein antigen (CP)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Candida mannan mitogen (CM)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Staphylococcus aureus protein A (SPA)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: T cell-depleted marrows
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Grades II-IV acute GVHD
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Confirmed invasive Candida infection
Number of subjects: 133
Study: 6311788

Group type: EXPERIMENTAL
Intervention: Ceftazidime
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Cefsulodin
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Cefoperazone
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Latamoxef (moxalactam)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 111
Study: 31260642

Group type: EXPERIMENTAL
Intervention: Mailed informational packet followed by a tailored telephone‐delivered brief motivational interview
Number of subjects: 204

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 204
Study: 29221471

Group type: EXPERIMENTAL
Intervention: In-home balance and proprioceptive training
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Hospital supervised balance and proprioceptive training
Number of subjects: 75

Group type: COMPARATOR
Intervention: Non-active control group
Number of subjects: 75
Study: 25928879

Group type: EXPERIMENTAL
Intervention: Pentaerythritol tetranitrate (PETN) 80 mg/kg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 23523456

Group type: EXPERIMENTAL
Intervention: CABG
Number of subjects: 1800

Group type: COMPARATOR
Intervention: PCI
Number of subjects: 1800
Study: 21740262

Group type: EXPERIMENTAL
Intervention: Fast-track postoperative care
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional postoperative care
Number of subjects: 50
Study: 19958867

Group type: EXPERIMENTAL
Intervention: Elinogrel (10, 20, 40, and 60 mg) administered as a single intravenous bolus before primary PCI
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Elinogrel (all doses)
Number of subjects: 70
Study: 17108847

Group type: EXPERIMENTAL
Intervention: Testosterone patch releasing 300 microg/24 hours
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 99
Study: 14742401

Group type: EXPERIMENTAL
Intervention: Hemispheric synchronization (Hemi-Sync) musical recording
Number of subjects: 2

Group type: COMPARATOR
Intervention: Blank tape (control group)
Number of subjects: 2
Study: 11300389

Group type: COMPARATOR
Intervention: Fentanyl 10 microg x ml(‐1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Fentanyl combined with ropivacaine 1 mg x ml(‐1)
Number of subjects: 40
Study: 9623379

Group type: COMPARATOR
Intervention: Laparoscopic hernia repair
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Open hernia repair
Number of subjects: 20
Study: 8688400

Group type: EXPERIMENTAL
Intervention: 600 mg mifepristone
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 200 mg mifepristone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both groups (600 mg and 200 mg mifepristone)
Number of subjects: 70
Study: 2176947

Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 10 micrograms min‐1 kg‐1
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 5 micrograms min‐1 kg‐1
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Dopamine infusion at 2 micrograms min‐1 kg‐1
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (5% D‐glucose infusion)
Number of subjects: 5
Study: 7000063

Group type: EXPERIMENTAL
Intervention: Metronidazole and Cefazolin
Number of subjects: 271

Group type: COMPARATOR
Intervention: Metronidazole and Placebo
Number of subjects: 271

Group type: COMPARATOR
Intervention: Cefazolin and Placebo
Number of subjects: 271

Group type: COMPARATOR
Intervention: Double Placebo
Number of subjects: 271
Study: 31091980

Group type: EXPERIMENTAL
Intervention: Combined intervention (exercise + nutrition education)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Nutrition education
Number of subjects: 229

Group type: COMPARATOR
Intervention: Control
Number of subjects: 229
Study: 27032628

Group type: EXPERIMENTAL
Intervention: Citalopram (30 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 25203371

Group type: EXPERIMENTAL
Intervention: Defunctioning stoma
Number of subjects: 123

Group type: COMPARATOR
Intervention: No stoma
Number of subjects: 123
Study: 21865723

Group type: EXPERIMENTAL
Intervention: Theta-burst rTMS
Number of subjects: 22
Study: 21519764

Group type: EXPERIMENTAL
Intervention: Balanced energy formula diet (200 Kcal every 6 hours for 12 days)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Low-calorie regular diet (no carbs or fat)
Number of subjects: 120
Study: 17945035

Group type: EXPERIMENTAL
Intervention: Oxaliplatin 130 mg/m² on day 1 plus capecitabine 2000 mg/m² daily on days 1-15 (series I)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Oxaliplatin 85 mg/m² on day 1 plus capecitabine 2000 mg/m² daily on days 1-15 (series II)
Number of subjects: 42
Study: 16267371

Group type: EXPERIMENTAL
Intervention: 10-minute back massage, three times a week for 10 sessions
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group relaxed in the same environment for 10 min, three times a week for 10 sessions
Number of subjects: 14
Study: 12081122

Group type: EXPERIMENTAL
Intervention: Study group (leaflet with risk factors and access to geriatric clinic)
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1043

Group type: EXPERIMENTAL
Intervention: Study group
Number of subjects: 1043
Study: 9407262

Group type: EXPERIMENTAL
Intervention: IDEAL model intervention
Number of subjects: 16
Study: 8220940

Group type: EXPERIMENTAL
Intervention: naproxen 500 mg twice daily for 2 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 3612776

Group type: EXPERIMENTAL
Intervention: Smoking prevention program emphasizing refusal skills training
Number of subjects: 1730

Group type: COMPARATOR
Intervention: No-treatment condition (Control)
Number of subjects: 1730
Study: 29288788

Group type: EXPERIMENTAL
Intervention: Nephrostomy tract infiltration (NTI) with 20 mL of 0.25% ropivacaine and epinephrine (n=32)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intercostal nerve block with 15 mL of 0.5% ropivacaine and epinephrine (n=32)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (n=32)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 96
Study: 26079158

Group type: EXPERIMENTAL
Intervention: Anxiety Relief (iCBT)
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Insomnia Relief (iCBT)
Number of subjects: 138

Group type: COMPARATOR
Intervention: Control
Number of subjects: 138
Study: 24767232

Group type: EXPERIMENTAL
Intervention: PAP therapy for 18 months
Number of subjects: 51
Study: 22624286

Group type: EXPERIMENTAL
Intervention: Performance before the earthquake
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Performance after the earthquake
Number of subjects: 16
Study: 20070284

Group type: EXPERIMENTAL
Intervention: peginterferon alfa-2a (90 microg/week)
Number of subjects: 1049

Group type: COMPARATOR
Intervention: No additional treatment
Number of subjects: 1049

Group type: EXPERIMENTAL
Intervention: Clinical progression of chronic hepatitis C
Number of subjects: 1049